We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What are the Different Types of Acute Myelogenous Leukemia Treatment?

By H. Colledge
Updated May 17, 2024
Our promise to you
WiseGeek is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGeek, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Acute myelogenous leukemia, or AML, is a form of cancer which develops from cells inside the bone marrow which would normally have gone on to form white blood cells. It is the most common type of acute, or rapidly developing, leukemia in adults. Different types of acute myelogenous leukemia treatment are available, including chemotherapy, where drugs are used to kill cancer cells, and radiotherapy, which uses radiation for the same purpose. A stem cell transplant can restore normal blood-forming cells to the bone marrow. Treating acute myelogenous leukemia may also involve the use of other drugs or new methods still being trialled.

The symptoms of acute myelogenous leukemia can include tiredness, fever, increased infections and bleeding from areas of the body such as the gums. Treatment for acute myelogenous leukemia usually consists of two separate phases. In the first phase, remission induction therapy, the aim is to destroy cancer cells in the bone marrow and blood. The second phase, known as post-remission or consolidation therapy, aims to kill any cancer cells left behind after the first phase of treatment. This second phase is carried out to lower the chance of the cancer recurring.

During the remission induction therapy phase of acute myelogenous leukemia treatment, the main treatment method used is chemotherapy. Chemotherapy drugs may be given by injection or taken as tablets, so that they reach the cancer cells via the blood stream. Sometimes the drugs are directly injected into the body at the cancer site. Most often it is necessary to remain in the hospital while remission induction therapy is carried out, as the acute myelogenous leukemia treatment causes a number of side effects and suppresses the body's immune system, making infections more of a risk. Sometimes, other drugs are used in combination with the chemotherapy treatment, or by themselves, for certain types of AML.

The consolidation therapy phase of acute myelogenous leukemia treatment can involve what is known as a bone marrow, or stem cell, transplant. First, chemotherapy or radiotherapy are used to kill the abnormal bone marrow tissue from which the cancer cells developed. Next, donated stem cells are used to replace the bone marrow which was destroyed. There is no single best acute myelogenous leukemia treatment, and trials continue to seek new and more effective therapies. Those acute myelogenous leukemia treatments which are available provide a cure for only some patients, with younger people generally having a better outlook.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.